Metacycline Market by Therapeutics (Chronic Bronchitis, Rickettsial Infections, Pneumonia, Trench Fever, Typhus, Q Fever, Sinusitis, and Others) - Global Opportunity Analysis and Industry Forecast, 2020-2027
|
LI_183605
|
Pages: NA
|
Jan 2020 |
1364 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Metacycline is a broad spectrum semisynthetic antibiotic that belongs to tetracycline drug class. Esarondil, physiomycine, lysocline, and rotilen are some of the brand names of the antibiotic. Metacycline inhibits protein synthesis and hence cell growth by preventing the binding of aminoacyl transfer RNA to the m-RNA-ribosome complex in the ribosome 30S subunit. The antibiotic is administered in the form of oral tablets.
The wide spectrum of antimicrobial action with the use of metacyclin makes it an active component against gram-positive and gram-negative bacteria. The increase in the incidence of diseases such as rickettsiae, pneumonia, sinusitis, trench fever, and typhus increases the demand for metacycline, which in turn boosts the market growth. Nevertheless, the adverse effects associated with the use of metacycline such as hepatotoxicity, diarrhea, nausea, enterocolitis, and diarrhea hamper the market growth. In addition, the rise in the number of antibiotic resistant organisms and availability of substitutes such as miciclin, monatrex, and muvito also limit the growth of the market.
The global metacycline market is segmented based on application and geography. Based on therapeutics, it is classified into chronic bronchitis, rickettsial infections, pneumonia, trench fever, typhus, Q fever, sinusitis, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as Merck, Boc Sciences, Manus Aktteva Biopharma LLP, Cayman Chemical, Hycultec GmbH, Abcam plc, Santa Cruz Biotechnology, Inc., Hlzel Biotech, Changzhou Pharmaceutical Factory, and The ND Pharma & Biotech Company are also provided in the report.
Key Benefits
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global metacycline market.
- This report entails the detailed quantitative analysis of the current market and estimations through 2017-2023, which assists in identifying the prevailing market opportunities.
- The projections in this report are made by analyzing the current trends and future market potential from 2017 to 2023 in terms of value.
- Competitive intelligence (of leading manufacturers and distributors of disposable gloves) helps understand the competitive scenario across the geographies
- An in-depth analysis of current research and clinical developments within the market is provided with key market dynamic factors that help understand the behavior of the market.
Metacycline Market Key Segments:
By Therapeutics
- Chronic bronchitis
- Rickettsial infections
- Pneumonia
- Trench fever
- Typhus
- Q fever
- Sinusitis
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest ofEurope
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1INTRODUCTION
1.1.REPORT DESCRIPTION
1.2.KEY BENEFITS
1.3.KEY MARKET SEGMENTS
1.4.RESEARCH METHODOLOGY
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2EXECUTIVE SUMMARY
2.1.CXO PERSPECTIVE
CHAPTER 3MARKET OVERVIEW
3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.MARKET SHARE ANALYSIS, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS
3.4.1.MARKET DYNAMICS
3.4.2.Drivers
3.4.3.Restraints
3.4.4.Opportunities
CHAPTER 4METACYCLINE MARKET, BY THERAPEUTICS
4.1.OVERVIEW
4.1.1.Market size and forecast
4.2.CHRONIC BRONCHITIS
4.2.1.Key market trends
4.2.2.Growth factors and opportunities
4.2.3.Market size and forecast
4.3.RICKETTSIAL INFECTIONS
4.3.1.Key market trends
4.3.2.Growth factors and opportunities
4.3.3.Market size and forecast
4.4.PNEUMONIA
4.4.1.Key market trends
4.4.2.Growth factors and opportunities
4.4.3.Market size and forecast
4.5.TRENCH FEVER
4.5.1.Key market trends
4.5.2.Growth factors and opportunities
4.5.3.Market size and forecast
4.6.TYPHUS
4.6.1.Key market trends
4.6.2.Growth factors and opportunities
4.6.3.Market size and forecast
4.7.Q FEVER
4.7.1.Key market trends
4.7.2.Growth factors and opportunities
4.7.3.Market size and forecast
4.8.SINUSITIS
4.8.1.Key market trends
4.8.2.Growth factors and opportunities
4.8.3.Market size and forecast
4.9.OTHERS
4.9.1.Key market trends
4.9.2.Growth factors and opportunities
4.9.3.Market size and forecast
CHAPTER 5METACYCLINE MARKET, BY GEOGRAPHY
5.1.OVERVIEW
5.2.NORTH AMERICA
5.2.1.Key market trends
5.2.2.Key growth factors and opportunities
5.2.3.Market size and forecast
5.2.3.1.U.S. market size and forecast
5.2.3.2.Canada market size and forecast
5.2.3.3.Mexico market size and forecast
5.2.4.North America Metacycline Market by Therapeutics
5.3.EUROPE
5.3.1.Key market trends
5.3.2.Key growth factors and opportunities
5.3.3.Market size and forecast
5.3.3.1.Germany market size and forecast
5.3.3.2.France market size and forecast
5.3.3.3.UK market size and forecast
5.3.3.4.Italy market size and forecast
5.3.3.5.Spain market size and forecast
5.3.3.6.Rest of Europe market size and forecast
5.3.4.Europe Metacycline Market by Therapeutics
5.4.ASIA-PACIFIC
5.4.1.Key market trends
5.4.2.Key growth factors and opportunities
5.4.3.Market size and forecast
5.4.3.1.Japan market size and forecast
5.4.3.2.China market size and forecast
5.4.3.3.Australia market size and forecast
5.4.3.4.India market size and forecast
5.4.3.5.South Korea market size and forecast
5.4.3.6.Taiwan market size and forecast
5.4.3.7.Rest of Asia-Pacific market size and forecast
5.4.4.Asia-Pacific Metacycline Market by Therapeutics
5.5.LAMEA
5.5.1.Key market trends
5.5.2.Key growth factors and opportunities
5.5.3.Market size and forecast
5.5.3.1.Brazil market size and forecast
5.5.3.2.Turkey market size and forecast
5.5.3.3.Saudi Arabia market size and forecast
5.5.3.4.South Africa market size and forecast
5.5.3.5.Rest of LAMEA market size and forecast
5.5.4.LAMEA Metacycline Market by Therapeutics
CHAPTER 6COMPANY PROFILES
6.1.MERCK
6.1.1.Operating business segments
6.1.2.Business performance
6.1.3.Key strategic moves and developments
6.2.BOC SCIENCES
6.2.1.Operating business segments
6.2.2.Business performance
6.2.3.Key strategic moves and developments
6.3.MANUS AKTTEVA BIOPHARMA LLP
6.3.1.Operating business segments
6.3.2.Business performance
6.3.3.Key strategic moves and developments
6.4.CAYMAN CHEMICAL
6.4.1.Operating business segments
6.4.2.Business performance
6.4.3.Key strategic moves and developments
6.5.HYCULTEC GMBH
6.5.1.Operating business segments
6.5.2.Business performance
6.5.3.Key strategic moves and developments
6.6.ABCAM PLC
6.6.1.Operating business segments
6.6.2.Business performance
6.6.3.Key strategic moves and developments
6.7.SANTA CRUZ BIOTECHNOLOGY, INC.
6.7.1.Operating business segments
6.7.2.Business performance
6.7.3.Key strategic moves and developments
6.8.HÖLZEL BIOTECH
6.8.1.Operating business segments
6.8.2.Business performance
6.8.3.Key strategic moves and developments
6.9.CHANGZHOU PHARMACEUTICAL FACTORY
6.9.1.Operating business segments
6.9.2.Business performance
6.9.3.Key strategic moves and developments
6.10.ND PHARMA & BIOTECH COMPANY
6.10.1.Operating business segments
6.10.2.Business performance
6.10.3.Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Metacycline Market- Global Opportunity Analysis and Industry Forecast, 2020-2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.